Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 590

1.

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.

Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R.

Aliment Pharmacol Ther. 2012 Jul;36(1):22-9. doi: 10.1111/j.1365-2036.2012.05121.x. Epub 2012 May 3.

2.

Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.

Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R.

Aliment Pharmacol Ther. 2013 Mar;37(6):630-9. doi: 10.1111/apt.12237. Epub 2013 Feb 5.

3.

A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.

Idilman IS, Keskin O, Celik A, Savas B, Halil Elhan A, Idilman R, Karcaaltincaba M.

Acta Radiol. 2016 Mar;57(3):271-8. doi: 10.1177/0284185115580488. Epub 2015 Apr 8.

PMID:
25855666
4.

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB.

Radiology. 2013 May;267(2):422-31. doi: 10.1148/radiol.12120896. Epub 2013 Feb 4.

5.

Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.

Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M.

Radiology. 2013 Jun;267(3):767-75. doi: 10.1148/radiol.13121360. Epub 2013 Feb 4.

PMID:
23382293
6.

Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

Kalra N, Duseja A, Das A, Dhiman RK, Virmani V, Chawla Y, Singh P, Khandelwal N.

Ann Hepatol. 2009 Jan-Mar;8(1):21-5.

PMID:
19221529
7.

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A.

Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.

8.

Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.

Idilman IS, Keskin O, Elhan AH, Idilman R, Karcaaltincaba M.

Scand J Gastroenterol. 2014 May;49(5):617-24. doi: 10.3109/00365521.2014.894118. Epub 2014 Apr 2.

PMID:
24694249
9.

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.

Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C, Loomba R.

Hepatology. 2013 Dec;58(6):1930-40. doi: 10.1002/hep.26455. Epub 2013 Oct 17.

10.

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, Horsfall L, Jothimani D, Fawcett J, Galloway GJ, Benson M, Powell EE.

J Hepatol. 2009 Aug;51(2):389-97. doi: 10.1016/j.jhep.2009.04.012. Epub 2009 May 18.

PMID:
19505740
11.

Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.

Vongsuvanh R, George J, McLeod D, van der Poorten D.

J Hepatol. 2012 Aug;57(2):392-8. doi: 10.1016/j.jhep.2012.03.013. Epub 2012 Apr 17.

PMID:
22521350
12.

MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.

Ligabue G, Besutti G, Scaglioni R, Stentarelli C, Guaraldi G.

Quant Imaging Med Surg. 2013 Aug;3(4):192-5. doi: 10.3978/j.issn.2223-4292.2013.08.01.

13.

Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.

Lin SC, Heba E, Wolfson T, Ang B, Gamst A, Han A, Erdman JW Jr, O'Brien WD Jr, Andre MP, Sirlin CB, Loomba R.

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1337-1345.e6. doi: 10.1016/j.cgh.2014.11.027. Epub 2014 Dec 3.

14.

Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.

Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS, Peterson M, Loomba R, Sirlin CB.

Radiology. 2015 Feb;274(2):416-25. doi: 10.1148/radiol.14140754. Epub 2014 Sep 22.

15.

Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.

Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, Lam J, Hooker JC, Hamilton G, Fontanesi J, Sirlin CB.

Hepatology. 2015 Jun;61(6):1887-95. doi: 10.1002/hep.27666. Epub 2015 Feb 5.

16.

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, Nguyen P, Hernandez C, Richards L, Salotti J, Lin S, Seki E, Nelson KE, Sirlin CB, Brenner D; Genetics of NAFLD in Twins Consortium.

Gastroenterology. 2015 Dec;149(7):1784-93. doi: 10.1053/j.gastro.2015.08.011. Epub 2015 Aug 20.

PMID:
26299412
17.

Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.

Arulanandan A, Ang B, Bettencourt R, Hooker J, Behling C, Lin GY, Valasek MA, Ix JH, Schnabl B, Sirlin CB, Loomba R.

Clin Gastroenterol Hepatol. 2015 Aug;13(8):1513-20.e1. doi: 10.1016/j.cgh.2015.01.027. Epub 2015 Feb 3.

PMID:
25661453
18.

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).

Raszeja-Wyszomirska J, Szymanik B, Ławniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M.

BMC Gastroenterol. 2010 Jun 28;10:67. doi: 10.1186/1471-230X-10-67.

19.

Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.

Calvo N, Beltrán-Debón R, Rodríguez-Gallego E, Hernández-Aguilera A, Guirro M, Mariné-Casadó R, Millá L, Alegret JM, Sabench F, del Castillo D, Vinaixa M, Rodríguez MÀ, Correig X, García-Álvarez R, Menendez JA, Camps J, Joven J.

World J Gastroenterol. 2015 Jun 28;21(24):7529-44. doi: 10.3748/wjg.v21.i24.7529.

20.

Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.

Idilman IS, Tuzun A, Savas B, Elhan AH, Celik A, Idilman R, Karcaaltincaba M.

Abdom Imaging. 2015 Aug;40(6):1512-9. doi: 10.1007/s00261-015-0385-0.

PMID:
25715922
Items per page

Supplemental Content

Write to the Help Desk